Compared with lean controls or obesity, patients with T2D display decreased Akk abundance and elevated Firmicutes–Bacteroidetes ratio, and GLP1-agonist therapy intervention increased Akk abundance in T2D during the study period [65]. This evidence concerns the gene GCG and type 2 diabetes mellitus.